Skip to main content
Forte Biosciences, Inc. logo

Forte Biosciences, Inc. — Investor Relations & Filings

Ticker · FBRX ISIN · US8888461022 LEI · 529900Z84WFDHPS3JP76 US Manufacturing
Filings indexed 503 across all filing types
Latest filing 2025-02-07 Registration Form
Country US United States of America
Listing US FBRX

About Forte Biosciences, Inc.

https://www.fortebiorx.com/home/default…

Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for autoimmune and autoimmune-related diseases. The company's lead product candidate is FB-102, a proprietary molecule with potentially broad applications. Forte is advancing FB-102 through clinical trials for several indications, including celiac disease, vitiligo, and alopecia areata.

Recent filings

Filing Released Lang Actions
S-8 Filing
Registration Form
2025-02-07 English
8-K Filing
Regulatory Filings
2025-01-24 English
SCHEDULE 13G Filing
Major Shareholding Notification
2025-01-10 English
4 Filing
Director's Dealing
2025-01-02 English
4 Filing
Director's Dealing
2025-01-02 English
DEF 14A Filing
Proxy Solicitation & Information Statement
2024-12-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.